BridgeMD
New treatment option for Caries; Dentin
Official title SMART With Different Modifications in Asymptomatic Deep Carious Lesions of Primary Molars.
ClinicalTrials.gov ID: NCT06645860
What this study is testing
- What it's testing
- This study aimed to evaluate the clinical success of the 'Silver Modified Atraumatic Restorative Technique '(SMART) with different modifications in asymptomatic deep carious lesions of primary molars.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 9. Healthy volunteers may be eligible.
You may be able to join if
- Patients and parents of the patients who accept to participate and sign the informed consent.
- Children between the ages of 4-9
- Healthy children without a history of serious systemic conditions necessitating chronic use of medications.
- Children whose dental examination reveals at least one untreated asymptomatic cavitated carious lesion (ICDAS II index: code 4,5,6) affecting primary...
- Absence of former history of spontaneous pain from the offending tooth/teeth.
You likely can't join if
- Patients and parents of the patients who does not accept to participate and sign the informed consent
- Patients with proven allergy to silver compounds or any component of dental materials to be applied.
- Patients with special health care needs or any medical conditions.
- Primary molar teeth with excessive crown damage that cannot be restored.
- Primary molar teeth in which bone loss exceeds 1/3 of the roots.
- Primary molar teeth that have previously undergone root canal treatment or pulpotomy treatment.
See the full eligibility criteria
- Patients and parents of the patients who accept to participate and sign the informed consent.
- Children between the ages of 4-9
- Healthy children without a history of serious systemic conditions necessitating chronic use of medications.
- Children whose dental examination reveals at least one untreated asymptomatic cavitated carious lesion (ICDAS II index: code 4,5,6) affecting primary molars.
- Absence of former history of spontaneous pain from the offending tooth/teeth.
- Patients with an appropriate level of cooperation to complete treatment under clinical conditions.
- Teeth are in a restorable condition.
- Natural exfoliation of primary teeth to be treated should not be expected within two years.
- Patients and parents of the patients who does not accept to participate and sign the informed consent
- Patients with proven allergy to silver compounds or any component of dental materials to be applied.
- Patients with special health care needs or any medical conditions.
- Primary molar teeth with excessive crown damage that cannot be restored.
- Primary molar teeth in which bone loss exceeds 1/3 of the roots.
- Primary molar teeth that have previously undergone root canal treatment or pulpotomy treatment.
- Presence of internal/external and root resorption in primary teeth to be treated.
- Root fracture, ankylosis or mobility in the primary teeth to be treated.
The study team makes the final eligibility decision.
Where it's taking place
- Çanakkale, Kepez, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 9 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Çanakkale, Kepez, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.